{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:02:13Z","timestamp":1780534933706,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K11143"],"award-info":[{"award-number":["24K11143"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Karoji Memorial Fund for Medical Research in Hirosaki University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-026-02291-w","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:08:45Z","timestamp":1780531725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alteration of small intestinal microbiota in diet-induced steatohepatitis mice"],"prefix":"10.1007","volume":"75","author":[{"given":"Go","family":"Soma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuto","family":"Omura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuki","family":"Tachizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michi","family":"Izawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Yoshizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kabasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikara","family":"Iino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoh","family":"Matsumiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadaatsu","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotake","family":"Sakuraba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"2291_CR1","doi-asserted-by":"publisher","unstructured":"Rinella\u200c ME, Neuschwander-Tetri\u200c. BA,\u200c Siddiqui\u200c MS,\u200c Abdelmalek MF, Caldwell S, et\u200c al.\u200c AASLD\u200c Practice\u200c Guidance\u200c on\u200c the\u200c clinical\u200c assessment\u200c and\u200c management\u200c of\u200c nonalcoholic\u200c fatty\u200c liver\u200c disease.\u200c Hepatology. \u200c2023;\u200c77:\u200c1797\u2009\u2013\u2009835. https:\/\/doi.org\/10.1097\/HEP.0000000000000323","DOI":"10.1097\/HEP.0000000000000323"},{"key":"2291_CR2","doi-asserted-by":"publisher","unstructured":"European\u200c Association\u200c. for\u200c the\u200c Study\u200c of\u200c the\u200c Liver\u200c (EASL);\u200c European\u200c Association\u200c for\u200c the\u200c Study\u200c of\u200c Diabetes\u200c (EASD);\u200c European\u200c Association\u200c for\u200c the\u200c Study\u200c of\u200c Obesity\u200c (EASO).\u200c EASL-EASD-EASO\u200c Clinical\u200c Practice\u200c Guidelines\u200c on\u200c the\u200c management\u200c of\u200c metabolic\u200c dysfunction-associated\u200c steatotic\u200c liver\u200c disease\u200c (MASLD). \u200cJ \u200cHepatol.\u200c 2024;\u200c81:\u200c492\u2013542. https:\/\/doi.org\/10.1016\/j.jhep.2024.04.031","DOI":"10.1016\/j.jhep.2024.04.031"},{"key":"2291_CR3","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jhep.2023.03.038","volume":"79","author":"F Tacke","year":"2023","unstructured":"Tacke F, Puengel T, Loomba R, Friedman S. An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH. J Hepatol. 2023;79:552\u201366. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.038.","journal-title":"J Hepatol"},{"key":"2291_CR4","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52:1836\u201346. https:\/\/doi.org\/10.1002\/hep.24001.","journal-title":"Hepatology"},{"key":"2291_CR5","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/hep.31056","volume":"72","author":"G Carpino","year":"2020","unstructured":"Carpino G, Del Ben M, Pastori D, Carnevale R, Baratta F, et al. Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD. Hepatology. 2020;72:470\u201385. https:\/\/doi.org\/10.1002\/hep.31056.","journal-title":"Hepatology"},{"key":"2291_CR6","doi-asserted-by":"publisher","first-page":"e1002533","DOI":"10.1371\/journal.pbio.1002533","volume":"14","author":"R Sender","year":"2016","unstructured":"Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14:e1002533. https:\/\/doi.org\/10.1371\/journal.pbio.1002533.","journal-title":"PLoS Biol"},{"key":"2291_CR7","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.tim.2024.02.013","volume":"32","author":"S Yersin","year":"2024","unstructured":"Yersin S, Vonaesch P. Small intestinal microbiota: from taxonomic composition to metabolism. Trends Microbiol. 2024;32:970\u201383. https:\/\/doi.org\/10.1016\/j.tim.2024.02.013.","journal-title":"Trends Microbiol"},{"key":"2291_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41586-020-2971-8","volume":"588","author":"J Schluter","year":"2020","unstructured":"Schluter J, Peled JU, Taylor BP, Markey KA, Smith M, et al. The gut microbiota is associated with immune cell dynamics in humans. Nature. 2020;588:303\u20137. https:\/\/doi.org\/10.1038\/s41586-020-2971-8.","journal-title":"Nature"},{"key":"2291_CR9","doi-asserted-by":"publisher","first-page":"2201155","DOI":"10.1080\/19490976.2023.2201155","volume":"15","author":"RA Ruigrok","year":"2023","unstructured":"Ruigrok RA, Weersma R, Vila AV. The emerging role of the small intestinal microbiota in human health and disease. Gut Microbes. 2023;15:2201155. https:\/\/doi.org\/10.1080\/19490976.2023.2201155.","journal-title":"Gut Microbes"},{"key":"2291_CR10","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1016\/j.cell.2021.07.001","volume":"184","author":"JF Brooks 2nd","year":"2021","unstructured":"Brooks JF 2nd, Behrendt CL, Ruhn KA, Lee S, Raj P, et al. The microbiota coordinates diurnal rhythms in innate immunity with the circadian clock. Cell. 2021;184:4154\u2013e6712. https:\/\/doi.org\/10.1016\/j.cell.2021.07.001.","journal-title":"Cell"},{"key":"2291_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41385-019-0227-4","volume":"13","author":"O Pabst","year":"2020","unstructured":"Pabst O, Slack E. IgA and the intestinal microbiota: the importance of being specific. Mucosal Immunol. 2020;13:12\u201321. https:\/\/doi.org\/10.1038\/s41385-019-0227-4.","journal-title":"Mucosal Immunol"},{"key":"2291_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","volume":"139","author":"II Ivanov","year":"2009","unstructured":"Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139:485\u201398. https:\/\/doi.org\/10.1016\/j.cell.2009.09.033.","journal-title":"Cell"},{"key":"2291_CR13","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.jhep.2011.02.035","volume":"55","author":"E G\u00e4bele","year":"2011","unstructured":"G\u00e4bele E, Dostert K, Hofmann C, Wiest R, Sch\u00f6lmerich J, et al. DSS Induced Colitis Increases Portal LPS Levels and Enhances Hepatic Inflammation and Fibrogenesis in Experimental NASH. J Hepatol. 2011;55:1391\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2011.02.035.","journal-title":"J Hepatol"},{"key":"2291_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/labinvest.2014.11","volume":"94","author":"W Liang","year":"2014","unstructured":"Liang W, Lindeman JH, Menke AL, Koonen DP, Morrison M, et al. Metabolically Induced Liver Inflammation Leads to NASH and Differs from LPS- or IL-1\u03b2-Induced Chronic Inflammation. Lab Invest. 2014;94:491\u2013502. https:\/\/doi.org\/10.1038\/labinvest.2014.11.","journal-title":"Lab Invest"},{"key":"2291_CR15","doi-asserted-by":"publisher","first-page":"e0277930","DOI":"10.1371\/journal.pone.0277930","volume":"17","author":"T Tateda","year":"2022","unstructured":"Tateda T, Iino C, Sasada T, Sato S, Igarashi G, et al. Evaluation of metabolic dysfunction-associated fatty liver disease using FibroScan, diet, and microbiota: A large cross-sectional study. PLoS ONE. 2022;17:e0277930. https:\/\/doi.org\/10.1371\/journal.pone.0277930.","journal-title":"PLoS ONE"},{"key":"2291_CR16","doi-asserted-by":"publisher","first-page":"8096","DOI":"10.1038\/srep08096","volume":"5","author":"W Jiang","year":"2015","unstructured":"Jiang W, Wu N, Wang X, Chi Y, Zhang Y, et al. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci Rep. 2015;5:8096. https:\/\/doi.org\/10.1038\/srep08096.","journal-title":"Sci Rep"},{"key":"2291_CR17","doi-asserted-by":"publisher","first-page":"818","DOI":"10.7150\/ijbs.56214","volume":"17","author":"A Khan","year":"2021","unstructured":"Khan A, Ding Z, Ishaq M, Bacha AS, Khan I, et al. Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates. Int J Biol Sci. 2021;17:818\u201333. https:\/\/doi.org\/10.7150\/ijbs.56214.","journal-title":"Int J Biol Sci"},{"key":"2291_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/iep.12008","volume":"94","author":"M Matsumoto","year":"2013","unstructured":"Matsumoto M, Hada N, Sakamaki Y, Uno A, Shiga T, et al. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. Int J Exp Pathol. 2013;94:93\u2013103. https:\/\/doi.org\/10.1111\/iep.12008.","journal-title":"Int J Exp Pathol"},{"key":"2291_CR19","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1099\/00207713-45-4-780","volume":"45","author":"J Snel","year":"1995","unstructured":"Snel J, Heinen PP, Blok HJ, Carman RJ, Duncan AJ, et al. Comparison of 16S rRNA sequences of segmented filamentous bacteria isolated from mice, rats, and chickens and proposal of Candidatus Arthromitus. Int J Syst Bacteriol. 1995;45:780\u20132. https:\/\/doi.org\/10.1099\/00207713-45-4-780.","journal-title":"Int J Syst Bacteriol"},{"key":"2291_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1574-6968.1992.tb04986.x","volume":"8","author":"HL Klaasen","year":"1992","unstructured":"Klaasen HL, Koopman JP, Poelma FG, Beynen AC. Intestinal, segmented, filamentous bacteria. FEMS Microbiol Rev. 1992;8:165\u201380. https:\/\/doi.org\/10.1111\/j.1574-6968.1992.tb04986.x.","journal-title":"FEMS Microbiol Rev"},{"key":"2291_CR21","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.immuni.2014.03.009","volume":"40","author":"E L\u00e9cuyer","year":"2014","unstructured":"L\u00e9cuyer E, Rakotobe S, Lenglin\u00e9-Garnier H, Lebreton C, Picard M, et al. Segmented filamentous bacterium uses secondary and tertiary lymphoid tissues to induce gut IgA and specific T helper 17-cell responses. Immunity. 2014;40:608\u201320. https:\/\/doi.org\/10.1016\/j.immuni.2014.03.009.","journal-title":"Immunity"},{"key":"2291_CR22","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/s12276-025-01535-9","volume":"57","author":"E Park","year":"2025","unstructured":"Park E, Ciofani M. Th17 cell pathogenicity in autoimmune disease. Exp Mol Med. 2025;57:1913\u201327. https:\/\/doi.org\/10.1038\/s12276-025-01535-9.","journal-title":"Exp Mol Med"},{"key":"2291_CR23","doi-asserted-by":"publisher","first-page":"e0368821","DOI":"10.1128\/mbio.03688-21","volume":"13","author":"S He","year":"2022","unstructured":"He S, Cui S, Song W, Jiang Y, Chen H, et al. Interleukin-17 Weakens the NAFLD\/NASH Process by Facilitating Intestinal Barrier Restoration Depending on the Gut Microbiota. mBio. 2022;13:e0368821. https:\/\/doi.org\/10.1128\/mbio.03688-21.","journal-title":"mBio"},{"key":"2291_CR24","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s10875-010-9368-7","volume":"30","author":"C Blaschitz","year":"2010","unstructured":"Blaschitz C, Raffatellu M. Th17 cytokines and the gut mucosal barrier. J Clin Immunol. 2010;30:196\u2013203. https:\/\/doi.org\/10.1007\/s10875-010-9368-7.","journal-title":"J Clin Immunol"},{"key":"2291_CR25","doi-asserted-by":"publisher","first-page":"3360310","DOI":"10.1155\/2023\/3360310","volume":"2023","author":"L Sun","year":"2023","unstructured":"Sun L, Wang L, Moore B, Zhang B, Xiao S. IL-17: Balancing protective immunity and pathogenesis. J Immunol Res. 2023;2023:3360310. https:\/\/doi.org\/10.1155\/2023\/3360310.","journal-title":"J Immunol Res"},{"key":"2291_CR26","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jcmgh.2021.05.010","volume":"12","author":"S Ganguly","year":"2021","unstructured":"Ganguly S, Muench GA, Shang L, Rosenthal SB, Rahman G, et al. Nonalcoholic steatohepatitis and HCC in a hyperphagic mouse accelerated by western diet. Cell Mol Gastroenterol Hepatol. 2021;12:891\u2013920. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.05.010.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2291_CR27","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.cgh.2013.02.015","volume":"11","author":"M Raman","year":"2013","unstructured":"Raman M, Ahmed I, Gillevet PM, Probert CS, Ratcliffe NM, Smith S, et al. Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2013;11:868\u201375. https:\/\/doi.org\/10.1016\/j.cgh.2013.02.015. .e1-3.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2291_CR28","doi-asserted-by":"publisher","first-page":"G151","DOI":"10.1152\/ajpgi.00198.2014","volume":"308","author":"H Okubo","year":"2015","unstructured":"Okubo H, Nakatsu Y, Sakoda H, Kushiyama A, Fujishiro M, et al. Mosapride citrate improves nonalcoholic steatohepatitis with increased fecal lactic acid bacteria and plasma glucagon-like peptide-1 level in a rodent model. Am J Physiol Gastrointest Liver Physiol. 2015;308:G151\u20138. https:\/\/doi.org\/10.1152\/ajpgi.00198.2014.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2291_CR29","doi-asserted-by":"publisher","first-page":"300060520978122","DOI":"10.1177\/0300060520978122","volume":"48","author":"C Li","year":"2020","unstructured":"Li C, Cui L, Wang X, Yan Z, Wang S, Zheng Y. Using intestinal flora to distinguish non-alcoholic steatohepatitis from non-alcoholic fatty liver. J Int Med Res. 2020;48:300060520978122. https:\/\/doi.org\/10.1177\/0300060520978122.","journal-title":"J Int Med Res"},{"key":"2291_CR30","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3389\/fmicb.2018.01953","volume":"9","author":"J Wang","year":"2018","unstructured":"Wang J, Ji H, Wang S, Liu H, Zhang W, et al. Probiotic Lactobacillus plantarum Promotes Intestinal Barrier Function by Strengthening the Epithelium and Modulating Gut Microbiota. Front Immunol. 2018;9:1953. https:\/\/doi.org\/10.3389\/fmicb.2018.01953.","journal-title":"Front Immunol"},{"key":"2291_CR31","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.3390\/life12111910","volume":"12","author":"D Qin","year":"2022","unstructured":"Qin D, Ma Y, Wang Y, Hou X, Yu L. Contribution of Lactobacilli on Intestinal Mucosal Barrier and Diseases: Perspectives and Challenges of Lactobacillus casei. Life (Basel). 2022;12:1910. https:\/\/doi.org\/10.3390\/life12111910.","journal-title":"Life (Basel)"},{"key":"2291_CR32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.chom.2016.01.003","volume":"19","author":"L Wang","year":"2016","unstructured":"Wang L, Fouts DE, Starkel P, Hartmann P, Chen P, et al. Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing mucosa-associated microbiota and preventing bacterial translocation. Cell Host Microbe. 2016;19:227\u201339. https:\/\/doi.org\/10.1016\/j.chom.2016.01.003.","journal-title":"Cell Host Microbe"},{"key":"2291_CR33","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3389\/fimmu.2017.01063","volume":"8","author":"Y Huang","year":"2017","unstructured":"Huang Y, Qi HB, Zhang Z, Wang E, Yun H, et al. Gut REG3\u03b3-Associated Lactobacillus Induces Anti-inflammatory Macrophages to Maintain Adipose Tissue Homeostasis. Front Immunol. 2017;8:1063. https:\/\/doi.org\/10.3389\/fimmu.2017.01063.","journal-title":"Front Immunol"},{"key":"2291_CR34","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.cmet.2022.09.024","volume":"34","author":"JH Shin","year":"2022","unstructured":"Shin JH, Bozadjieva-Kramer N, Shao Y, Lyons-Abbott S, Rupp AC, et al. The gut peptide Reg3g links the small intestine microbiome to the regulation of energy balance, glucose levels, and gut function. Cell Metab. 2022;34:1765\u2013e786. https:\/\/doi.org\/10.1016\/j.cmet.2022.09.024.","journal-title":"Cell Metab"},{"key":"2291_CR35","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1038\/s12276-023-01054-5","volume":"55","author":"JH Shin","year":"2023","unstructured":"Shin JH, Bozadjieva-Kramer N, Seeley RJ. Reg3g: current understanding and future therapeutic opportunities in metabolic disease. Exp Mol Med. 2023;55:1672\u20137. https:\/\/doi.org\/10.1038\/s12276-023-01054-5.","journal-title":"Exp Mol Med"},{"key":"2291_CR36","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1038\/s41598-023-30997-y","volume":"13","author":"S Nakamura","year":"2023","unstructured":"Nakamura S, Nakamura K, Yokoi Y, Shimizu Y, Ohira S, et al. Decreased Paneth cell \u03b1-defensins promote fibrosis in a choline-deficient L-amino acid-defined high-fat diet-induced mouse model of nonalcoholic steatohepatitis via disrupting intestinal microbiota. Sci Rep. 2023;13:3953. https:\/\/doi.org\/10.1038\/s41598-023-30997-y.","journal-title":"Sci Rep"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02291-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02291-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02291-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:08:45Z","timestamp":1780531725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02291-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2291"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02291-w","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"26 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"All animal experiments were conducted in accordance with the Guidelines for AnimalExperimentation of the Hirosaki University (Permit number: 2024-136, 2025-068)","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"131"}}